Skip to content

Pharmacokinetics of sugammadex for the reversal of moderate neuromuscular blockade in patients during renal transplantation

Pharmacokinetics of sugammadex for the reversal of moderate neuromuscular blockade in patients during renal transplantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052926
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease

Interventions

Elective general surgery group in supine position:medical treatement
Renal transplantation Group(S group):medical treatement

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing emergency kidney transplantation under general anesthesia (creatinine clearance CLCR=80ml/min); 2. Aged 18 to 65 years; 3. ASA classification I ~ III.

Exclusion criteria

Exclusion criteria: 1. Suffering from neuromuscular disease, liver dysfunction, heart disease and personal or family history of malignant hyperthermia; 2. Pregnant or breastfeeding women; 3. Difficult airway, sleep apnea syndrome and body mass index >= 28kg/m^2; 4. Patients who have taken the following drugs recently: aminoglycoside antibiotics, anticonvulsants, magnesium, and perioperative toremifene, fusidic acid and flucloxacillin.

Design outcomes

Primary

MeasureTime frame
Pharmacokinetic parameters ;

Secondary

MeasureTime frame
Average time from start of dosing to recovery of T4/T1 ratio to 0.7, 0.8, 0.9;Residual muscle relaxation, including hypoxemia, TOF ratio < 0.9, head-up < 5 seconds;

Countries

China

Contacts

Public ContactTang Yiyang

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

157769414@qq.com+86 13751869517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026